Thiazolidinedione Intervention With Vitamin D Evaluation
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This study will answer two separate questions.
The first question is to test the cardiovascular effects of long-term treatment with
rosiglitazone or pioglitazone when used as part of standard of care compared to similar
standard of care without rosiglitazone or pioglitazone in patients with type 2 diabetes who
have a history of or are at risk for cardiovascular disease.
The second question will compare the effects of long-term supplementation of vitamin D on
death and cancer
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Collaborators:
Academic Research Collaborator: Population Health Research Institute / Hamilton Health Population Health Research Institute
Treatments:
2,4-thiazolidinedione Ergocalciferols Pioglitazone Rosiglitazone Vitamin D Vitamins